Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 213

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis

Open access
Feng, Xudong, Li, Shuangshuang, Sun, Qiang, Zhu, Jiaqi, Chen, Bo, Xiong, Maoming, Cao, Guodong · 2020 · Frontiers in Medicine

Abstract

Background The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly spreading on a global scale and posed great threat to human health. Acute respiratory distress syndrome, characterized by a rapid onset of generalized inflammation, is the leading cause of mortality of patients with COVID-19. Thus, we aimed to explore the effect of risk factors on the severity of the disease, focusing on immune-inflammatory parameters which represent the immune status of patients. Methods A comprehensive systematic search for relevant studies published up to April 2020 was performed by using PubMed, Web of Science, EMBASE, China National Knowledge Internet (CNKI) databases. After extracting all available data of immune-inflammatory indicators, we statistically analyzed the risk factors of severe and nonsevere COVID-19 patients with meta-analysis. Results A total number of 4911 patients from 29 studies were finally included in the meta-analysis. The results demonstrated that severe patients tend to present higher level of white blood cell (WBC), neutrophil, neutrophil-lymphocyte ratio (NLR), procalcitonin (PCT), C-reaction protein (CRP), erythrocyte sedimentation rate (ESR) and Interleukin-6 (IL-6) and decreased number of total lymphocyte and lymphocyte subtypes such as CD4+ T lymphocyte and CD8+ T lymphocyte compared to the nonsevere patients. In addition, WBC count>10ⅹ109/L, lymphocyte count0.5ng/mL, CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10ⅹ109/L: OR=2.92, 95%CI: 1.96-4.35; lymphocyte count0.5ng/mL: OR=6.33, 95%CI: 3.97-10.10; CRP>10 mg/L: OR=3.51, 95%CI: 2.38-5.16). Furthermore, we found that NLR, as a novel marker of systemic inflammatory response, can also help predict clinical severity in patients with COVID‐19 (OR=2.50, 95%CI: 2.04-3.06). Conclusions Immune-inflammatory parameters such as WBC, lymphocyte, PCT, CRP and NLR could imply the progression of COVID-19. NLR has taken both the levels of neutrophil and lymphocyte into account, indicating a more complete, accurate and reliable inspection efficiency; surveillance of NLR may help clinicians identify high risk COVID-19 patients at an early stage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2020.00301

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 213

Metadata

Authors
Feng, X., Li, S., Sun, Q., Zhu, J., Chen, B., Xiong, M., & Cao, G.
Venue
Frontiers in Medicine
Published
2020-06-09
Volume
7
Pages
301-301
ISSN
2296-858X (ISSN-L)
OpenAlex
W3034448873
Cited by
213
References
11
FWCI
2.57
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.3389/fmed.2020.00301
The paper
Feng, X., Li, S., Sun, Q., Zhu, J., Chen, B., Xiong, M., & Cao, G. (2020). Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis. Frontiers in Medicine. https://doi.org/10.3389/fmed.2020.00301

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.